Transcatheter Aortic Valve Replacement (TAVR) News
transcatheter heart valves
11/03/2026
Anteris Technologies Global Corp. announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492...
Anteris Technologies Global Corp. announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492...
Anteris Technologies Global...
11/03/2026
Cath Lab Digest
TAVR for Moderate AS
11/02/2026
In a randomized trial of patients with moderate AS and at least one at-risk feature, those who underwent earlier TAVR had improved outcomes at two years than those managed with clinical surveillance.
In a randomized trial of patients with moderate AS and at least one at-risk feature, those who underwent earlier TAVR had improved outcomes at two years than those managed with clinical surveillance.
In a randomized trial of...
11/02/2026
Cath Lab Digest
SCAI 2026
04/27/2026
Search patterns reveal differences in awareness across rural and low-volume treatment areas.
Search patterns reveal differences in awareness across rural and low-volume treatment areas.
Search patterns reveal...
04/27/2026
Journal of Invasive Cardiology
ACC 2026
03/30/2026
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next,...
03/30/2026
Cath Lab Digest